TAG:
Quest Diagnostics
Labcorp and Quest Execs Support RESULTS Act Progress
By Mark Terry | From the Volume XXXIII, No. 8 – June, 2026 Issue
Chief executives at both Labcorp and Quest Diagnostics reported year-over-year revenue growth in the first quarter during recent earnings calls, especially in specialty and consumer testing. They also indicated the companies are watching the progress of the RESULTS Act in Congress in hopes that it wi…
Labs Looking at Cash-Based Options Face Complexity
By Stephen Beale | From the Volume XXXIII, No. 7 – May 26, 2026 Issue
Given all the challenges of dealing with payers, many clinical laboratories find themselves tempted by the idea of offering cash-based business lines such as direct-to-consumer (DTC) testing. The patient pays up front and undergoes the test, and the lab banks the…
Three Signals to Take from Executive War College
By R. Lewis Dark | From the Volume XXXIII, No. 6 – May 04, 2026 Issue
We’ve arrived back from New Orleans and the 3…
Direct-to-Consumer Clinical Laboratory Testing is Booming
By Mark Terry | From the Volume XXXIII, No. 6 – May 04, 2026 Issue
As part of the ongoing and expanding healthcare direct-to-consumer (DTC) wellness trend, DTC laboratory testing is on the rise. It is driven by increasing at-home care, effective and affordable telehealth approaches, and significantly more convenient sampling and…
In Earnings Calls, Execs at Quest and Labcorp Push for RESULTS Act
By Mark Terry | From the Volume XXXIII, No. 4 – March 23, 2026 Issue
Chief executives at Labcorp and Quest Diagnostics made it clear during recent investor calls that they want Congress to pass the RESULTS Act. The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act is seen b…
Translating Genomic Testing to the Clinic
By Mark Terry | From the Volume XXXIII, No. 1 – January 19, 2026 Issue
CEO SUMMARY: An entrepreneur in the liquid biopsy sector outlines a series of questions to answer if a diagnostic innovation is to ever succeed in the commercial marketplace. Scientists and businesspeople will want to ask about a potential product’s significance, uniquen…
Top Stories in 2025 Played Out in Courts, Capitol Hill
By Janette Wider | From the Volume XXXII, No. 18 – December 29, 2025 Issue
CEO SUMMARY: The biggest story of the year for clinical laboratories came in a huge court victory, as a federal judge vacated the FDA’s final rule on laboratory developed tests. Labs breathed a sigh of relief after the court decision, as the FDA rule had promised to incr…
Strategies to Succeed with Laboratory Outreach Programs
By Stephen Beale | From the Volume XXXII, No. 18 – December 29, 2025 Issue
In recent years Labcorp and Quest Diagnostics went on buying sprees, acquiring laboratory outreach businesses from major health systems. They argue that they can run these operations more efficiently, while the sellers get much-needed cash infusions. (See …
One Lab’s Solution to Its Histotechnologist Shortage
By Jillia Schlingman | From the Volume XXXII, No. 18 – December 29, 2025 Issue
Histology workforce shortages remain one of the major challenges within the clinical laboratory industry, and, unfortunately, as the demand for histotechnologists increases, the number of qualified personnel has been decreasing. A report releas…
December 29, 2025, Intelligence: Late-Breaking Lab News
By Janette Wider | From the Volume XXXII, No. 18 – December 29, 2025 Issue
The US Department of Veterans Affairs (VA) is expanding its use of precision medicine through a new multi-year contract with Baylor Genetics to provide pharmacogenomic (PGx) and germline genetic testing to veterans across the VA’s nationwide healthcare system. The agreement includes P…
CURRENT ISSUE
Volume XXXIII, No. 9 – July, 2026
Newsmaker Interview with Revvity’s Yves Dubaquie > How Specialty Diagnostic Tests Connect with Lab Customers: In this exclusive Q&A, Revvity’s Yves Dubaquie provides details about the in vitro diagnostics company’s priorities, including developing specialty tests and reviewing its business in China. Dubaquie also explains why clinical laboratories may need to consider hiring more technology-savvy workers in the future as the complexity of instruments grows.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized